Merck CFO: Cladribine Approval Process ‘Well on Track’

Marcus Kuhnert, chief financial officer at Merck, discusses the company’s earnings and progress of new drug treatments. He speaks with Anna Edwards and Caroline Hyde on Bloomberg Television’s “On The Move.” (Source: Bloomberg)

Full Show: Bloomberg Daybreak: Americas (09/20)
40:29 - Bloomberg Daybreak: Americas hosted by David Westin, Jonathan Ferro, and Alix Steel. Guests include Stephen Ross, chairman at Related Companies, John Ryding, chief economist at RDQ Economics, and James Sweeney, chief economist at Credit Suisse AG. (Source: Bloomberg)
  • Greece's Papadimitriou on Bailout, Debt Relief, NPLs
  • Lasry Says Market Will Take 'Big Hit' Without Tax Reform
  • Inside China's Under-the-Radar Bond Boom